Vania Manolova

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 4

Top Topics

Sickle Cell Disease

Candida Albicans

Computed Tomography

Top Venues

Expert review of hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Naja Nyffenegger, Anna Flace, Ahmet Varol, Patrick Altermatt, Cédric Doucerain, Hanna Sundstrom, Franz Dürrenberger, Vania Manolova
The oral ferroportin inhibitor vamifeport prevents liver iron overload in a mouse model of hemochromatosis. HemaSphere 8 (9) (2024)
Jan Stetka, Marc Usart, Lucia Kubovcakova, Shivam Rai, Tata Nageswara Rao, Joshua Sutter, Hui Hao-Shen, Stefan Dirnhofer, Florian Geier, Michael Stephan Bader, Jakob R Passweg, Vania Manolova, Franz Dürrenberger, Nouraiz Ahmed, Timm Schroeder, Tomas Ganz, Elizabeta Nemeth, Laura Silvestri, Antonella Nai, Clara Camaschella, Radek C Skoda
Iron is a modifier of the phenotypes of JAK2-mutant myeloproliferative neoplasms. Blood (2023)
Naja Nyffenegger, Rahima Zennadi, Natarajaswamy Kalleda, Anna Flace, Giada Ingoglia, Raphael M Buzzi, Cédric Doucerain, Paul W Buehler, Dominik J Schaer, Franz Dürrenberger, Vania Manolova
The oral ferroportin inhibitor vamifeport improves hemodynamics in a mouse model of sickle cell disease. Blood 140 (7) (2022)
John B Porter, Ali T Taher, Vip Viprakasit, Antonios Kattamis, Thomas D Coates, Maciej W Garbowski, Franz Dürrenberger, Vania Manolova, Frank Richard, Maria Domenica Cappellini
Oral ferroportin inhibitor vamifeport for improving iron homeostasis and erythropoiesis in β-thalassemia: current evidence and future clinical development. Expert review of hematology 14 (7) (2021)